SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 113.33 |
| Enterprise Value ($M) | 92.20 |
| Book Value ($M) | 144.27 |
| Book Value / Share | 2.25 |
| Price / Book | 0.79 |
| NCAV ($M) | 139.58 |
| NCAV / Share | 2.18 |
| Price / NCAV | 0.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.64 |
| Return on Assets (ROA) | -0.38 |
| Return on Equity (ROE) | -0.41 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.48 |
| Current Ratio | 7.48 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 165.49 |
| Assets | 170.18 |
| Liabilities | 25.90 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -90.89 |
| Net Income | -80.60 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -70.76 |
| Cash from Investing | -85.39 |
| Cash from Financing | 161.88 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 9.10 | -13.52 | |
| 13G/A | Goldman Sachs Group Inc | 4.10 | -42.11 | |
| 13G/A | BlackRock, Inc. | 4.80 | -5.70 | |
| 13G | Opaleye Management Inc. | 6.17 | 153.36 | |
| 13G/A | Verition Fund Management LLC | 0.90 | -78.87 | |
| 13G/A | Blue Owl Capital Holdings LP | 6.53 | 22.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| General and Administrative Expenses | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 354,902 | 990,204 | 35.84 | |
| 324,759 | 1,134,614 | 28.62 | |
| 185,812 | 1,241,881 | 14.96 | |
| 138,963 | 721,599 | 19.26 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KYMR – Kymera Therapeutics, Inc. | LGND – Ligand Pharmaceuticals Incorporated |
| LNTH – Lantheus Holdings, Inc. | LXEO – Lexeo Therapeutics, Inc. |
| MDWD – MediWound Ltd. |
Financial data and stock pages provided by
Fintel.io